SSB
GCVRZ

Sandy Spring Bank’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Sandy Spring Bank’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10
Closed – – 835
2014
Q2 		$0 Buy
+10
New +$5 ﹤0.01% 843

Other funds holding GCVRZ

WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Sandy Spring Bank's GCVRZ Position: Q3 2014 in Review

Sandy Spring Bank sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2014, closing a stake of 10 shares.

Sandy Spring Bank first reported a position in GCVRZ in Q2 2014 and held it in 1 quarter. The position peaked at $0 in Q2 2014. 118 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2014.

  • Sandy Spring Bank reported no remaining Sanofi Contingent Value Rights position as of Q3 2014 after selling out during the quarter.
  • Sandy Spring Bank sold 10 Sanofi Contingent Value Rights shares in Q3 2014.
  • Sandy Spring Bank first reported a position in Sanofi Contingent Value Rights in Q2 2014 and held it in 1 quarter.
  • Sandy Spring Bank's Sanofi Contingent Value Rights position peaked at $0 in Q2 2014.
  • 118 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2014.

Based on Sandy Spring Bank's 13F filing for Q3 2014, filed 14 Nov 2014.